Swan Defence and Heavy Industries to Resume Share Trading on NSE and BSE

Swan Defence and Heavy Industries Limited (SDHI), a prominent player in India’s commercial and defense

Read More

Cipla receives six observations from USFDA following Goa facility inspection

Cipla Ltd, announced on Friday (June 21) that its manufacturing facility in Goa, India, underwent

Read More

USFDA closes inspection of Lupin’s Nagpur Facility with zero observations

Lupin announced that the United States Food and Drug Administration (USFDA) has completed its inspection

Read More

Torrent Pharma’s Indrad Facility receives Form 483 with 5 observations from US FDA

Torrent Pharma, has announced that its manufacturing facility in Indrad, Gujarat, has received a Form

Read More

Dr Reddy’s manufacturing unit receives observations from US FDA

Dr Reddy’s Laboratories Ltd, a prominent pharmaceutical company based in Hyderabad, announced on Friday that

Read More

Lupin’s Somerset Facility receives Form-483 with six Observations

Lupin Limited has announced that the US Food and Drug Administration (FDA) concluded a pre-approval

Read More

USFDA inspection at Solara’s Visakhapatnam Facility completed without any Observations

Solara Active Pharma, a leading provider of Active Pharmaceutical Ingredients (API), has announced that the

Read More

USFDA Issues Form 483 with 1 Inspectional Observation to Cipla’s Kurkumbh Unit

Pharmaceutical giant Cipla Ltd disclosed on Wednesday that it has received one inspectional observation in

Read More